EZCORP Acquires Controlling Interest in Founders One, LLC, Expanding Its Footprint by 105 Pawn Stores Across 12 Countries

EZCORP Acquires Controlling Interest in Founders One, LLC, Expanding Its Footprint by 105 Pawn Stores Across 12 Countries GlobeNewswire January 05, 2026 AUSTIN, Texas, Jan. 05, 2026 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ:EZPW) (“EZCORP” or the “Company”), a leading provider of pawn loans in the United States and Latin America, announced today the acquisition of […]

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee(TM) Urine Collection Device for FDA Review

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee(TM) Urine Collection Device for FDA Review GlobeNewswire January 05, 2026 BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate applications at the

Rogers Launches The Great Canadian Jersey

Rogers Launches The Great Canadian Jersey GlobeNewswire January 05, 2026 – Donate your old hockey jerseys to be a part of hockey history – – Connor McDavid and Marie-Philip Poulin kick-off donations today – TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Rogers launched today The Great Canadian Jersey, the latest installment of Rogers This Is

SpotOn GPS Fence launches the Nova Edition: A GPS fence offering 100% reliability

SpotOn GPS Fence launches the Nova Edition: A GPS fence offering 100% reliability The Nova Edition is the most accurate GPS dog fence on the market, significantly reducing GPS drift and setting a new standard for off-leash freedom for dogs. GlobeNewswire January 05, 2026 Manchester, New Hampshire, Jan. 05, 2026 (GLOBE NEWSWIRE) — For dog

AmpliTech Group Reports Unaudited Record FY2025 Revenue And Reaffirms $50M + FY2026 Revenue Outlook

AmpliTech Group Reports Unaudited Record FY2025 Revenue And Reaffirms $50M + FY2026 Revenue Outlook GlobeNewswire January 05, 2026 HAUPPAUGE, N.Y., Jan. 05, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG) (“AmpliTech” or the “Company”) today announced unaudited record full-year revenue of approximately $25 million for fiscal year 2025, up 163% YoY, exceeding analyst's expectations

Steakholder Foods: Twine Solutions Sells First TwineX1 System to TITV for Next-Generation Textile Application Development

Steakholder Foods: Twine Solutions Sells First TwineX1 System to TITV for Next-Generation Textile Application Development GlobeNewswire January 05, 2026 Rehovot, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — The TwineX1 is the world's only industrial, digital, waterless yarn and thread dyeing system that enables brands and manufacturers to produce custom colors instantly and directly at the

Greif, Inc. Announces 2026 First Quarter Earnings Release and Conference Call Dates

Greif, Inc. Announces 2026 First Quarter Earnings Release and Conference Call Dates GlobeNewswire January 05, 2026 DELAWARE, Ohio, Jan. 05, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it will report the company's 2026 first quarter financial results after the market closes on

Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the hospital setting GlobeNewswire January 05, 2026 SUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE)

BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12

BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 GlobeNewswire January 05, 2026 SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) — BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced the company will present at the

Humacyte Announces Planned Marketing Authorization Application for Symvess(R) in Israel

Humacyte Announces Planned Marketing Authorization Application for Symvess(R) in Israel GlobeNewswire January 05, 2026 – Expansion plans are based on requests for product access received from surgeons and hospitals in Israel – – Expansion of Symvess into other territories, including those in Europe and the Middle East, is also planned – DURHAM, N.C., Jan. 05,

Scroll to Top